FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202514.3+113.04%
Mar 31, 20246.7-180.96%
Mar 31, 2023-8.3-135.12%
Mar 31, 202223.6+85.33%
Mar 31, 202112.7-85261.09%
Mar 31, 2020-0-100.16%
Mar 31, 20199.4-3.45%
Mar 31, 20189.8-753.58%
Mar 31, 2017-1.5-116.55%
Mar 31, 20169-33.66%
Mar 31, 201513.6
AI Chat